Highly sensitivity adhesion molecules detection in hereditary haemochromatosis patients reveals altered expression

International Journal of Immunogenetics

Volumn 37, Issue 2, 2010, Pages 125-133

  Norris, S ^b   White, M ^b   Mankan, A K ^c   Lawless, M W ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX;

ADULT; AGED; CELL ADHESION MOLECULES; E-SELECTIN; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; IRON; L-SELECTIN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; P-SELECTIN; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 77953597728     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00904.x     Document Type: Article

References (50)

1. Adams, D.H., Mainolfi, E., Burra, P., Neuberger, J.M., Ayres, R., Elias, E., Rothlein, R. (1992) Detection of circulating intercellular adhesion molecule-1 chronic liver disease. Hepatology, 16, 810.
2. Albertini, J.P., Valensi, P., Lormeau, B., Aurousseau, M.H., Ferriere, F., Attali, J.R. & Gattegno, L. (1998) Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care, 21, 1008.
3. Arosa, F.A., Oliveira, L., Porto, G., da Silva, B.M., Kruijer, W., Veltman, J. & de Sousa, M. (1997) Anomalies of the CD8+ T cell pool in hemochromatosis: HLA-A3-linked expansion of CD+CD28- T cells. Clinical and Experimental Immunology, 107, 548.
4. Barthel, S.R., Gavino, J.D., Descheny, L. & Dimitroff, C.J. (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opinion on Therapeutic Targets, 11, 1473.
5. Barton, J.C., Wiener, H.W., Acton, R.T. & Go, R.C. (2005) Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes. BMC Blood Disorders, 5,5.
6. Benekli, M., Gullu, I.H., Tekuzman, G., Savas, M.C., Hayran, M., Hascelik, G. & Firat, D. (1998) Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer. British Journal of Cancer, 78, 267.
7. Berrahmoune, H., Lamont, J.V., Herbeth, B., Fitzgerald, P.S. & Visvikis-Siest, S. (2006) Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattrac- tant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clinical Chemistry, 3, 504.
8. Cominacini, L., Fratta Pasini, A., Garbin, U., Davoli, A., De Santis, A., Campagnola, M., Rigoni, A., Zenti, M.G., Moghetti, P. & Lo Cascio, V. (1995) Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia, 38, 1122.
9. Constante, M., Jiang, W., Wang, D., Raymond, V.A., Bilodeau, M. & Santos, M.M. (2006) Distinct requirements of HFE in basal and induced hepcidin levels in iron overload and inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology, 2, 229.
10. Cruz, E., Melo, G., Lacerda, R., Almeida, S. & Porto, G. (2006) The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects. Blood Cells, Molecules, and Diseases, 37, 33.
11. Diecher, R. & Horl, W.H. (2006) New insights into the regulation of iron homeostasis. European Journal of Clinical Investigation, 5, 301.
12. Dooley, J. & Worwood, M. (2000) Guidelines on diagnosis and therapy-genetic haemochromatosis. British Committee for Standards in Haemoatology, 33,1
13. Dymicka-Piekarska, V. & Kemona, H. (2009) Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration? Thrombosis Research, 124, 80.
14. Eichbaum, M.H., de Rossi, T.M., Kaul, S. & Bastert, G. (2004) Serum levels of soluble E-selectin are associated with the clinical course of metastatic disease in patients with liver metastases from breast cancer. Oncology Research, 14, 603.
15. Etzioni, A. (2007) Leukocyte adhesion deficiencies: molecules basis, clinical findings, and therapeutic options. Advances in Experimental Medicine and Biology, 601, 51.
16. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A. et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399.
17. Fitzgerald, S.P., Lamont, J.V., McConnell, R.I. & Benchikh el, O. (2005) Development of a high-throughput automated analyzer using biochip array technology. Clinical Chemistry, 7, 1165.
18. Ganz, T. (2003) Hepcidin a key regulator of iron metabolism and mediator of anaemia of inflammation. Blood, 3, 783.
19. Gearing, A.J. & Newman, W. (1993) Circulating adhesion molecules in disease. Immunology Today, 14, 506.
20. Gearing, A.J.H., Hemingway, I., Pigott, R. et al. (1992) Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathological significance. Annals of the New York Academy of Sciences, 667, 324.
21. Gierer, P., Ibrahim, S., Mittlmeier, T., Koczan, D., Moeller, S., Landes, J., GradL, G. & Vollmar, B. (2005) Gene expression profile and synovial microcirculation at early stages of collagen induced arthritis. Arthritis Research and Therapy, 7, R868.
22. Gray, S.G., Crowe, J., Lawless, M.W. (2009) Hemochromatosis: As a conformational disorder. The International Journal of Biochemistry and Cell Biology, 41, 2094.
23. Jung, U. & Ley, K. (1999) Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. Journal of Immunology, 162, 6755.
24. Kartikasari, A.E.R., Georgiou, N.A., Visseren, F.L.J., van Kats-Renaud, H. & van Asbeck Marx, J.J.M. (2006) Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron presents in human sera. FASEB Journal, 20, 353.
25. Kuuliala, A., Eberhardt, K., Takala, A., Kautiainen, H., Repo, H. & Leirisalo-Repo, M. (2002) Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study. Annals of the Rheumatic Diseases, 61, 242.
26. Lauri, D., Needham, L., Martin-Padura, I. & Dejana, E. (1991) Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. Journal of the National Cancer Institute, 83, 1321.
27. Lawless, M. W., White, M., Mankan, A.K., O'Dwyer, M.J. & Norris, S. (2007) Elevated MCP-1 serum levels are assocatied with the H63D mutation and not the C282Y mutation in hereditary hemochroamtosis. Tissue Antigens, 70, 294.
28. Lee, P., Peng, H., Gelbart, T. & Beutler, E. (2004) The IL-6 and lipopolysaccharide-induced transcription of hepcidin inn HFE-, transferring receptor 2-, and beta 2-microglobulin-deficent hepatocytes. Proceedings of the National Academy of Sciences of the United States of America, 25, 9263.
29. Lee, P., Peng, H., Gelbart, T., Wang, L. & Beutler, E. (2005) Regulation of hepcidin transcription by interleukin-1 and inter-leukin-6. Proceedings of the National Academy of Sciences of the United States of America, 6, 1906.
30. Loreal, O. & Brissot, P. (2002) Hepcidin: the grail of iron metabolism. Gastroenterologie Clinique et Biologique, 8-9, 805.
31. Mainous, A.G., Gill, J.M. & Carek, P.J. (2004) Elevated serum transferring saturation and mortality. Annals of Family Medicine, 2, 133.
32. Molloy, R.M., McConnell, R.I., Lamont, J.V. & Fitzgerald, S.P. (2005) Automation of biochip array technology for quality results. Clinical Chemistry and Laboratory Medicine, 12, 1303.
33. Murtagh, L.J., Whiley, M., Wilson, S., Tran, H. & Bassett, M.L. (2002) Unsaturated iron binding capacity and transferring saturation are equally reliable in detection of HFE hemochromatosis. American Journal of Gastroenterology, 97, 2093.
34. O'hanlon, D.M., Fitzsimons, H., Lynch, J., Tormey, S., Malone, C. & Given, H.F. (2002) Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. European Journal of Cancer, 38, 2252.
35. Pietrangelo, A. (2006) Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut, 55, 564.
36. Pirisi, M., Falleti, E., Fabris, C., Soardo, G., Toniutto, P., Vitulli, D. et al. (1994) Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. American Journal of Clinical Pathology, 102, 600.
37. Porto, g. & De Sousa, M. (2007) Iron overload and immunity. World Journal of Gastroenterology, 13, 4707.
38. Porto, G., Vicente, C., Teixeira, M.A. et al. (1997) Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology, 25, 397.
39. Rodrigues, P., Lopes, C., Mascarenhas, C., Arosio, P., Porto, G. & De Sousa, M. (2006) Comaparative study between Hfe-/- and beta2m-/- mice: progression with age of iron status and liver pathology. International Journal of Experimental Pathology, 87, 317.
40. Rubin, L.A. & Nelson, D.L. (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Annals of Internal Medicine, 113, 619.
41. Sawada, R., Tsuboi, S. & Fukuda, M. (1994) Differential E-selectin dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metaastic potentials. Journal of Biological Chemistry, 269, 1425.
42. Seidelin, J.B., Nielsen, O.H. & Strom, J. (2002) Soluble L-selectin levels predict survival in sepsis. Intensive Care Medicine, 28, 1613.
43. Sheen-Chen, S.M., Eng, H.L., Huang, C.C. & Chen, W.J. (2004) Serum levels of soluble E-selectin in women with breast cancer. British Journal of Surgery, 91, 1578.
44. Siedel, J., Wahlefeld, A.W. & Ziegenhorn, J. (1984) A new iron ferrozine reagent without deproteinization. Clinical Chemistry, 30, 975.
45. Simon, S.I., Cherapanov, V., Nadra, I., Waddell, T.K., Seo, S.M., Wang, Q. et al. (1998) Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte-endothelial adhesion. Journal of Immunology, 61, 933.
46. Tavill, A.S. (2001) American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Assocation. Diagnosis and management of hemochromatosis. Hepatology, 33, 1321.
47. Uner, A., Akcali, Z. & Unsal, D. (2004) Serum levels of soluble E-selectin in colorectal cancer. Neoplasma, 51 , 269.
48. Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K. & Kaneko, S. (2008) Differential microRNA expression between hepatitis and Hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology, 49, 1098.
49. Wang, N., Thuraisingam, T., Fallaollita, L., Ding, A. & Radzioch, D. (2006) The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response. Cancer Research, 66, 3062.
50. Zohrens, G., Armbrust, T., Pirzer, U., Meyer Zum Buschenfelde, K. & Ramadori, G. (1993) Intracellular adhesion molecule-1 concenration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology, 18, 798.